Deep minimal residual disease assessment redefines outcome and unveils different modes of treatment resistance in standard and high-risk multiple myeloma
收藏NIAID Data Ecosystem2026-03-12 收录
下载链接：
https://www.ncbi.nlm.nih.gov/sra/SRP253204
下载链接
链接失效反馈官方服务：
资源简介：
mRNA profiles of tumor plasma cells derived from 40 multiple myeloma patients at diagnosis and at MRD Overall design: 40 multiple myeloma patients at diagnosis and at MRD
创建时间：
2021-02-04
